U.S. Markets close in 5 hrs 42 mins

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.4000+0.0200 (+1.45%)
As of 10:17AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.37
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 35.3300
52 Week Low 31.3700
50-Day Moving Average 31.5337
200-Day Moving Average 31.8296

Share Statistics

Avg Vol (3 month) 31.71M
Avg Vol (10 day) 3664.66k
Shares Outstanding 5107.11M
Float 41.1M
% Held by Insiders 15.23%
% Held by Institutions 1101.48%
Shares Short (Sep 29, 2020) 410.13M
Short Ratio (Sep 29, 2020) 412.22
Short % of Float (Sep 29, 2020) 435.04%
Short % of Shares Outstanding (Sep 29, 2020) 49.46%
Shares Short (prior month Aug 30, 2020) 413.59M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3May 20, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 12.26%
Operating Margin (ttm)25.19%

Management Effectiveness

Return on Assets (ttm)18.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)320.34M
Revenue Per Share (ttm)3.01
Quarterly Revenue Growth (yoy)-5.40%
Gross Profit (ttm)226.92M
EBITDA 82.53M
Net Income Avi to Common (ttm)39.27M
Diluted EPS (ttm)0.3690
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)201.87M
Total Cash Per Share (mrq)1.88
Total Debt (mrq)246.68M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.52
Book Value Per Share (mrq)-0.10

Cash Flow Statement

Operating Cash Flow (ttm)97.97M
Levered Free Cash Flow (ttm)96.28M